{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:39:10Z","timestamp":1792276750860,"version":"4.4.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Platelets play an essential role in primary hemostasis through bleeding and thromboembolism. Thus, the diagnosis or evaluation of impaired hereditary, acquired, and drug-related platelet dysfunction has become imperative. The assessment of the platelet function is too complex for routine platelet function study. The major methods involved in platelet function study include platelet function analyzer testing, thromboelastography, thromboelastometry, light transmission aggregometry, and flow cytometry. The current review article focuses on the methods with flow cytometry for immunophenotyping of platelet and evaluating platelet function for platelet disorders, especially in patients with thrombocytopenia. According to the consensus published by the International Society on Thrombosis and Haemostasis, for inherited and acquired platelet disorders, the two major measures by which flow cytometry determines platelet function are glycoprotein IIb\/IIIa\/P-selectin (CD62p) expression and percentage of leukocyte\u2013platelet aggregates. Using flow cytometry to determine platelet function has several advantages, including good sensitivity to low platelet counts, small blood volume required, and the nonnecessity of centrifugation. However, flow cytometry has still many limitations and challenges, with standardization for routine laboratory testing also proving difficult. Although flow cytometry is available for multipurpose and sensitive study of platelet functions at the same time, the challenging analysis gradually increases and needs to be addressed before reality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tcmj.tcmj_117_22","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:51:31Z","timestamp":1658796691000},"page":"381-387","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Flow cytometry for evaluating platelet immunophenotyping and function in patients with thrombocytopenia"],"prefix":"10.4103","volume":"34","author":[{"given":"Chih-Lung","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20240828","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/jth.14479","article-title":"Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH","volume":"17","author":"Megy","year":"2019","journal-title":"J Thromb Haemost"},{"key":"R2-6-20240828","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5482\/HAMO-14-09-0047","article-title":"Analysis of platelet function and dysfunction","volume":"35","author":"Jurk","year":"2015","journal-title":"Hamostaseologie"},{"key":"R4-6-20240828","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jth.12231","article-title":"Recommendations for the standardization of light transmission aggregometry: A consensus of the working party from the platelet physiology subcommittee of SSC\/ISTH","volume":"11","author":"Cattaneo","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R5-6-20240828","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3324\/haematol.10999","article-title":"Platelet aggregation studies: Autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count","volume":"92","author":"Cattaneo","year":"2007","journal-title":"Haematologica"},{"key":"R6-6-20240828","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1055\/s-2004-835671","article-title":"Application of flow cytometry to platelet disorders","volume":"30","author":"Linden","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"R7-6-20240828","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jth.12792","article-title":"Diagnosis of inherited platelet function disorders: Guidance from the SSC of the ISTH","volume":"13","author":"Gresele","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R8-6-20240828","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/jth.13952","article-title":"Validation of flow cytometric analysis of platelet function in patients with a suspected platelet function defect","volume":"16","author":"van Asten","year":"2018","journal-title":"J Thromb Haemost"},{"key":"R9-6-20240828","first-page":"367","article-title":"The platelet function analyzer (PFA-100): An update on its clinical use","volume":"51","author":"Franchini","year":"2005","journal-title":"Clin Lab"},{"key":"R10-6-20240828","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ajh.24620","article-title":"Clinical utility of closure times using the platelet function analyzer-100\/200","volume":"92","author":"Favaloro","year":"2017","journal-title":"Am J Hematol"},{"key":"R11-6-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2011.07.005","article-title":"Principles and practice of thromboelastography in clinical coagulation management and transfusion practice","volume":"26","author":"Bolliger","year":"2012","journal-title":"Transfus Med Rev"},{"key":"R12-6-20240828","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/bjh.12929","article-title":"Beyond the platelet count: Immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopenia","volume":"166","author":"Greene","year":"2014","journal-title":"Br J Haematol"},{"key":"R13-6-20240828","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-4939-7196-1_25","article-title":"Platelet function analyzed by light transmission aggregometry","volume":"1646","author":"Hvas","year":"2017","journal-title":"Methods Mol Biol"},{"key":"R14-6-20240828","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5045\/br.2021.2020232","article-title":"A comparative study between light transmission aggregometry and flow cytometric platelet aggregation test for the identification of platelet function defects in patients with bleeding","volume":"56","author":"Sharma","year":"2021","journal-title":"Blood Res"},{"key":"R15-6-20240828","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1182\/blood.V87.12.4925.bloodjournal87124925","article-title":"Flow cytometry: A clinical test of platelet function","volume":"87","author":"Michelson","year":"1996","journal-title":"Blood"},{"key":"R16-6-20240828","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/cyto.990090508","article-title":"Flow cytometric analysis of platelet surface antigens","volume":"9","author":"Marti","year":"1988","journal-title":"Cytometry"},{"key":"R17-6-20240828","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/09537109909169179","article-title":"A flow cytometric assay for the study of dense granule storage and release in human platelets","volume":"10","author":"Ramstr\u00f6m","year":"1999","journal-title":"Platelets"},{"key":"R18-6-20240828","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH14-11-0999","article-title":"A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders","volume":"114","author":"Mumford","year":"2015","journal-title":"Thromb Haemost"},{"key":"R19-6-20240828","doi-asserted-by":"crossref","first-page":"20A","DOI":"10.1016\/j.amjcard.2008.11.019","article-title":"Methods for the measurement of platelet function","volume":"103","author":"Michelson","year":"2009","journal-title":"Am J Cardiol"},{"key":"R20-6-20240828","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/rth2.12193","article-title":"Platelet function testing at low platelet counts: When can you trust your analysis?","volume":"3","author":"Bokn\u00e4s","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"R21-6-20240828","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/jth.12555","article-title":"Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders","volume":"12","author":"Dovlatova","year":"2014","journal-title":"J Thromb Haemost"},{"key":"R22-6-20240828","doi-asserted-by":"crossref","first-page":"e0211130","DOI":"10.1371\/journal.pone.0211130","article-title":"A simplified flow cytometric method for detection of inherited platelet disorders \u2013 A comparison to the gold standard light transmission aggregometry","volume":"14","author":"Navred","year":"2019","journal-title":"PLoS One"},{"key":"R23-6-20240828","first-page":"69","article-title":"Flow cytometry: Its applications in hematology","volume":"80","author":"Orfao","year":"1995","journal-title":"Haematologica"},{"key":"R24-6-20240828","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/scd.1.1993.2.387","article-title":"Introduction to flow cytometry: Principles, fluorochromes, instrument set-up, calibration","volume":"2","author":"Recktenwald","year":"1993","journal-title":"J Hematother"},{"key":"R25-6-20240828","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0955-3886(95)90002-0","article-title":"Principles of flow cytometry","volume":"16","author":"Mandy","year":"1995","journal-title":"Transfus Sci"},{"key":"R28-6-20240828","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood.V88.3.907.907","article-title":"Analysis of GPIIb\/IIIa receptor number by quantification of 7E3 binding to human platelets","volume":"88","author":"Wagner","year":"1996","journal-title":"Blood"},{"key":"R29-6-20240828","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.2821619","article-title":"New perspectives in cell adhesion: RGD and integrins","volume":"238","author":"Ruoslahti","year":"1987","journal-title":"Science"},{"key":"R30-6-20240828","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1097\/00003246-200205001-00025","article-title":"Platelet glycoprotein IIb\/IIIa antagonists: Lessons learned from clinical trials and future directions","volume":"30","author":"Leclerc","year":"2002","journal-title":"Crit Care Med"},{"key":"R31-6-20240828","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0076-6879(92)15068-N","article-title":"Platelet membrane glycoprotein IIb-IIIa complex: Purification, characterization, and reconstitution into phospholipid vesicles","volume":"215","author":"Phillips","year":"1992","journal-title":"Methods Enzymol"},{"key":"R32-6-20240828","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1172\/JCI116388","article-title":"The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin","volume":"91","author":"Nishibori","year":"1993","journal-title":"J Clin Invest"},{"key":"R33-6-20240828","doi-asserted-by":"crossref","first-page":"773027","DOI":"10.3389\/fchem.2021.773027","article-title":"Targeting selectins mediated biological activities with multivalent probes","volume":"9","author":"Ganesh","year":"2021","journal-title":"Front Chem"},{"key":"R34-6-20240828","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0065-2776(08)60623-9","article-title":"Leukocyte migration and adhesion","volume":"58","author":"Imhof","year":"1995","journal-title":"Adv Immunol"},{"key":"R35-6-20240828","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI20986","article-title":"Central role of the P2Y12 receptor in platelet activation","volume":"113","author":"Dorsam","year":"2004","journal-title":"J Clin Invest"},{"key":"R36-6-20240828","doi-asserted-by":"crossref","first-page":"46035","DOI":"10.1074\/jbc.M208519200","article-title":"Signaling through Gi family members in platelets. Redundancy and specificity in the regulation of adenylyl cyclase and other effectors","volume":"277","author":"Yang","year":"2002","journal-title":"J Biol Chem"},{"key":"R37-6-20240828","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"R38-6-20240828","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-019-0709-6","article-title":"Platelet integrin \u03b1IIb\u03b23: Signal transduction, regulation, and its therapeutic targeting","volume":"12","author":"Huang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R39-6-20240828","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1203\/00006450-199910000-00014","article-title":"Surface expression of major membrane glycoproteins on resting and TRAP-activated neonatal platelets","volume":"46","author":"Sim\u00e1k","year":"1999","journal-title":"Pediatr Res"},{"key":"R40-6-20240828","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-0038-1648173","article-title":"Immunological detection of activated platelets in clinical disorders","volume":"65","author":"Abrams","year":"1991","journal-title":"Thromb Haemost"},{"key":"R41-6-20240828","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1016\/S0021-9258(17)39154-8","article-title":"Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation","volume":"260","author":"Shattil","year":"1985","journal-title":"J Biol Chem"},{"key":"R42-6-20240828","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1182\/blood.V76.10.2017.2017","article-title":"Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies","volume":"76","author":"Ginsberg","year":"1990","journal-title":"Blood"},{"key":"R43-6-20240828","doi-asserted-by":"crossref","first-page":"e0192079","DOI":"10.1371\/journal.pone.0192079","article-title":"Standardization and reference ranges for whole blood platelet function measurements using a flow cytometric platelet activation test","volume":"13","author":"Huskens","year":"2018","journal-title":"PLoS One"},{"key":"R44-6-20240828","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-5223(94)70482-1","article-title":"Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass","volume":"107","author":"Rinder","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R45-6-20240828","doi-asserted-by":"crossref","first-page":"e000026","DOI":"10.1161\/JAHA.113.000026","article-title":"P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activity","volume":"2","author":"Berny-Lang","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"R46-6-20240828","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/01.RES.74.2.336","article-title":"Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage","volume":"74","author":"Kurose","year":"1994","journal-title":"Circ Res"},{"key":"R47-6-20240828","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2010-01-261206","article-title":"Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis","volume":"116","author":"Lievens","year":"2010","journal-title":"Blood"},{"key":"R48-6-20240828","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/09537104.2018.1430358","article-title":"Measuring and interpreting platelet-leukocyte aggregates","volume":"29","author":"Finsterbusch","year":"2018","journal-title":"Platelets"},{"key":"R49-6-20240828","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000444807","article-title":"Platelet interaction with innate immune cells","volume":"43","author":"Kral","year":"2016","journal-title":"Transfus Med Hemother"},{"key":"R50-6-20240828","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/hc3801.095588","article-title":"Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction","volume":"104","author":"Michelson","year":"2001","journal-title":"Circulation"},{"key":"R51-6-20240828","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.thromres.2015.07.009","article-title":"Using six-colour flow cytometry to analyse the activation and interaction of platelets and leukocytes \u2013 A new assay suitable for bench and bedside conditions","volume":"136","author":"Granja","year":"2015","journal-title":"Thromb Res"},{"key":"R52-6-20240828","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11239-015-1212-8","article-title":"Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals","volume":"40","author":"Nkambule","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"R53-6-20240828","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3390\/jcm10051114","article-title":"Platelet phenotyping and function testing in thrombocytopenia","volume":"10","author":"Jurk","year":"2021","journal-title":"J Clin Med"},{"key":"R54-6-20240828","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.1995.00430130095010","article-title":"Usefulness of patient interview in bleeding disorders","volume":"155","author":"Sr\u00e1mek","year":"1995","journal-title":"Arch Intern Med"},{"key":"R55-6-20240828","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1182\/asheducation-2005.1.396","article-title":"Inherited patelet disorders","volume":"2005","author":"Handin","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R56-6-20240828","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2018.214239","article-title":"Glanzmann thrombasthenia: Genetic basis and clinical correlates","volume":"105","author":"Botero","year":"2020","journal-title":"Haematologica"},{"key":"R57-6-20240828","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/cyto.b.21892","article-title":"Platelet immunophenotyping in health and inherited bleeding disorders, a review and practical hints","volume":"98","author":"Fouassier","year":"2020","journal-title":"Cytometry B Clin Cytom"},{"key":"R59-6-20240828","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1182\/blood.V68.1.173.173","article-title":"Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry","volume":"68","author":"Jennings","year":"1986","journal-title":"Blood"},{"key":"R60-6-20240828","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.2009.015990","article-title":"Diagnosis of platelet-type von Willebrand disease by flow cytometry","volume":"95","author":"Giannini","year":"2010","journal-title":"Haematologica"},{"key":"R61-6-20240828","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/jth.13675","article-title":"Measurement of platelet aggregation, independently of patient platelet count: A flow-cytometric approach","volume":"15","author":"Vinholt","year":"2017","journal-title":"J Thromb Haemost"},{"key":"R62-6-20240828","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/jth.15526","article-title":"Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology","volume":"19","author":"Frelinger","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R63-6-20240828","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/jcm11010118","article-title":"Platelet defects in acute myeloid leukemia-potential for hemorrhagic events","volume":"11","author":"Bumbea","year":"2021","journal-title":"J Clin Med"},{"key":"R64-6-20240828","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/j.1538-7836.2011.04506.x","article-title":"Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia","volume":"9","author":"Psaila","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R65-6-20240828","first-page":"93","article-title":"Platelet dysfunction in acute leukemias and myelodysplastic syndromes","volume":"49","author":"Vl\u0103d\u0103reanu","year":"2011","journal-title":"Rom J Intern Med"},{"key":"R66-6-20240828","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1182\/blood-2015-02-628461","article-title":"Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP","volume":"126","author":"Frelinger","year":"2015","journal-title":"Blood"},{"key":"R67-6-20240828","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/ajh.20720","article-title":"Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa","volume":"81","author":"Thekkedath","year":"2006","journal-title":"Am J Hematol"},{"key":"R68-6-20240828","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/ndt\/gfg185","article-title":"Impaired expression of glycoproteins on resting and stimulated platelets in uraemic patients","volume":"18","author":"Moal","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R69-6-20240828","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/09537104.2017.1349308","article-title":"Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis","volume":"29","author":"Vinholt","year":"2018","journal-title":"Platelets"},{"key":"R70-6-20240828","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1182\/blood.2020009774","article-title":"Acquired platelet GPVI receptor dysfunction in critically ill patients with sepsis","volume":"137","author":"Weiss","year":"2021","journal-title":"Blood"},{"key":"R71-6-20240828","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.thromres.2019.11.011","article-title":"Platelet function in patients with septic shock","volume":"185","author":"Laursen","year":"2020","journal-title":"Thromb Res"},{"key":"R72-6-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jth.13918","article-title":"Neighborhood watch","volume":"16","author":"Rosendaal","year":"2018","journal-title":"J Thromb Haemost"},{"key":"R73-6-20240828","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/eurheartj\/ehp159","article-title":"Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial","volume":"30","author":"Michelson","year":"2009","journal-title":"Eur Heart J"},{"key":"R74-6-20240828","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","article-title":"Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial","volume":"116","author":"Wiviott","year":"2007","journal-title":"Circulation"},{"key":"R75-6-20240828","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jacc.2015.12.062","article-title":"Platelet inhibition with ticagrelor 60 mg versus 90 mg twice daily in the PEGASUS-TIMI 54 trial","volume":"67","author":"Storey","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R76-6-20240828","doi-asserted-by":"crossref","first-page":"4N","DOI":"10.1016\/j.amjcard.2006.09.008","article-title":"Current options in platelet function testing","volume":"98","author":"Michelson","year":"2006","journal-title":"Am J Cardiol"},{"key":"R77-6-20240828","doi-asserted-by":"crossref","first-page":"106819","DOI":"10.1016\/j.vph.2020.106819","article-title":"Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity","volume":"136","author":"Lee","year":"2021","journal-title":"Vascul Pharmacol"},{"key":"R78-6-20240828","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.3390\/ijms222011199","article-title":"Multiparameter evaluation of the platelet-inhibitory effects of tyrosine kinase inhibitors used for cancer treatment","volume":"22","author":"Tullemans","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R79-6-20240828","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1111\/jth.14943","article-title":"Platelet function and bleeding in chronic lymphocytic leukemia and mantle cell lymphoma patients on ibrutinib","volume":"18","author":"Dmitrieva","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R80-6-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1076029619858409","article-title":"TKI-related platelet dysfunction does not correlate with bleeding in patients with chronic phase-chronic myeloid leukemia with complete hematological response","volume":"25","author":"Sener","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"R81-6-20240828","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/09537104.2018.1501470","article-title":"Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia","volume":"30","author":"Mezei","year":"2019","journal-title":"Platelets"},{"key":"R82-6-20240828","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2016.07.019","article-title":"The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state","volume":"145","author":"Alhawiti","year":"2016","journal-title":"Thromb Res"},{"key":"R83-6-20240828","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10456-018-9598-5","article-title":"Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab","volume":"21","author":"Walraven","year":"2018","journal-title":"Angiogenesis"},{"key":"R84-6-20240828","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11239-010-0539-4","article-title":"Recurrent myocardial infarction associated with gefitinib therapy","volume":"32","author":"Lynch","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"R85-6-20240828","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0038-1636901","article-title":"Toward flow cytometry based platelet function diagnostics","volume":"44","author":"van Asten","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"R86-6-20240828","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0035-1570082","article-title":"Platelet function determined by flow cytometry: New perspectives?","volume":"42","author":"Ramstr\u00f6m","year":"2016","journal-title":"Semin Thromb Hemost"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_117_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:06:44Z","timestamp":1787756804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_117_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_117_22","relation":{},"ISSN":["1016-3190"],"issn-type":[{"value":"1016-3190","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}